RPE65 and respiratory distress syndrome in premature infants: Moreover, ocular tissues are easily accessible for monitoring, supported by abundant animal models, well-defined monogenic mechanisms, and a regulatory precedent in the form of FDA-approved LCA2 gene therapy, all of which favor the clinical translation of BE and PE in IRDs.